Table of Content

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Microbiome Sequencing Services Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Technology
6.1 Sequencing by Synthesis (SBS)
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Sequencing by Ligation (SBL)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Pyrosequencing
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Sanger Sequencing
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast

7 Market Breakup by Research Type
7.1 Outsourced Research
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Internal Research
7.2.1 Market Trends
7.2.2 Market Forecast

8 Market Breakup by Laboratory Type
8.1 Dry Labs
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Wet Labs
8.2.1 Market Trends
8.2.2 Market Forecast

9 Market Breakup by Application
9.1 Shotgun Sequencing
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Targeted Gene Sequencing
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 RNA Sequencing
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Whole Genome Sequencing
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast

10 Market Breakup by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Research and Academic Institutes
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Others
10.3.1 Market Trends
10.3.2 Market Forecast

11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast

12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 BaseClear B.V.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.2 Clinical-Microbiomics A/S
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.3 Diversigen Inc (OraSure Technologies Inc.)
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.4 M?rieux NutriSciences
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.5 Metabiomics Corporation (BioSpherex LLC)
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.6 Microbiome Insights Inc.
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.7 Microbiome Therapeutics LLC
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.8 Molecular Research LP
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.9 Molzym GmbH & Co. KG
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.10 Resphera Biosciences LLC
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Shanghai Realbio Technology (RBT) Co. Ltd.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.12 Zymo Research Corporation
16.3.12.1 Company Overview
16.3.12.2 Product Portfolio